Neuropeptide Y produces anxiety via Y2-type receptors

Peptides

Volumn 19, Issue 2, 1998, Pages 359-363

  Nakajima, Masaharu ^a   Inui, Akio ^a   Asakawa, Akihiro ^a   Momose, Kazuhiro ^a   Ueno, Naohiko ^a   Teranishi, Arata ^a   Baba, Shigeaki ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Leu31, Pro34 NPY; Anxiogenesis; Anxiolysis; NPY13 36; Y1 receptors; Y2 receptors

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; VASOPRESSIN;

ANIMAL EXPERIMENT; ANTIDIURESIS; ANXIETY NEUROSIS; ARTICLE; LEARNING; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STEREOTAXIC SURGERY; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; RECEPTORS, NEUROPEPTIDE Y;

ANIMALIA;

EID: 0032005127     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00298-2     Document Type: Article

References (31)

1. 4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270:1995;26762-26765.
2. Blomqvist A. G., Herzog H. Y-receptor subtypes-how many more? TINS. 20:1997;294-298.
3. Biro E., Samyai Z., Penke B., Szabo G., Telegdy G. Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology. 57:1993;340-345.
4. Britton K. T., Morgan J., Rivier J., Vale W., Koob G. F. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology. 86:1985;170-174.
5. Al-Damluji S., Thomas R., White A., Besser M. Vasopressin mediates alpha 1-adrenergic stimulation of adrenocorticotropin secretion. Endocrinology. 126:1990;1989-1995.
6. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13:1993;73-86.
7. File S. E., Vellucci S. V. Studies on the role of ACTH and of 5-HT in anxiety, using an animal model. J. Pharm. Pharmacol. 30:1978;105-110.
8. Flood J. F., Hernandez E. H., Morley J. E. Modulation of memory processing by neuropeptide Y. Brain. Res. 421:1987;280-290.
9. 2 receptor subtype. J. Biol. Chem. 270:1995;26758-26761.
10. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L., Schaffhauser A. O., Whitebread S., Hofbauer K. G., Taber R. I., Branchek T. A., Weinshank R. L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (Lond.). 382:1996;168-171.
11. Gray, J. A. A theory of septo-hippocampal function. In: Broadbent, D. B.; McGaugh, J. L.; Mackintosh, N. J.; Posner, M. I.; Tulving, E.; Weiskrantz, L., Eds. The neuropsychology of anxiety: an enquiry into the function of the hippocampal system. Oxford University Press; 1982:256-299.
12. Handley S. L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behavior. Naunyn-Schimiedeberg's Arch. Pharmacol. 327:1984;1-5.
13. 1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. 59:1995;201-205.
14. 1 receptors in amygdala, and dissociation from food intake effects . Neuropsychopharmacology. 8:1993;357-363.
15. Heilig M., Soderpalm B., Engel J. A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology. 98:1989;524-529.
16. Hirosue Y., Inui A., Teranishi A., Miura M., Nakajima M., Okita M., Nakajima Y., Himori N., Baba S., Kasuga M. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am. J. Physiol. 265:1993;R481-R486.
17. Inoue T., Inui A., Okita M., Sakatani N., Oya M., Morioka H., Mizuno N., Oimomi M., Baba S. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Life Sci. 44:1989;1043-1051.
18. Inui, A.; Baba, S. Gastrointestinal peptide binding and function in the brain: emphasis on peptide YY. In: Muller, E. E.; MacLeod, R. M., Eds. Neuroendocrine perspectives. Springer-Verlag; 1990:133-173.
19. Inui A., Inoue T., Nakajima M., Okita M., Sakatani N., Okimura Y., Chihara K., Baba S. Brain neuropeptide Y in the control of adrenocorticotropic hormone secretion in the dog. Brain Res. 510:1990;211-215.
20. Inui A., Okita M., Inoue T., Sakatani N., Oya M., Morioka H., Shii K., Yokono K., Mizuno N., Baba S. Characterization of peptide YY receptors in the brain. Endocrinology. 124:1989;402-409.
21. Inui A., Sano K., Miura M., Hirosue Y., Nakajima M., Okita M., Baba S., Kasuga N. Evidence for further heterogeneity of the receptors for neuropeptide Y and peptide YY in tumor cell lines derived from neural crest. Endocrinology. 131:1992;2090-2096.
22. Landgraf R., Gerstberger R., Montkowski A., Probst J. C., Wotjak C. T., Holsboer F., Engelmann M. V1 receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci. 15:1995;4250-4258.
23. 1 type. J. Biol. Chem. 267:1992;10935-10938.
24. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 59:1995;229-239.
25. Lundell I., Blomqvist A. G., Berglund M. M., Schober D. A., Johmson D., Statnick M. A., Gadski R. A., Gehlert D. R., Larhammer D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270:1995;29123-29128.
26. Montgomery K. C. The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:1958;254-260.
27. Nakajima M., Inui A., Teranishi A., Miura M., Hirosue Y., Okita M., Himori N., Baba S., Kasuga M. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J. Pharmacol. Exp. Ther. 268:1994;1010-1014.
28. Panksepp, J. The psychoneurology of fear: evolutionary perspectives and the role of animal models in understanding human anxiety. In: Burrows, G. D.; Roth, M.; Noyes, R., Jr., Eds. Handbook of anxiety, Vol. 3. The neurobiology of anxiety. Elsevier Science; 1992:3-53.
29. Pellow S., Chopin P., File S. E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
30. Porter J. R., Sander L. D. The effect of cholecystokinin octapeptide on pituitary-adrenal hormone secretion. Regul. Pept. 2:1981;245-252.
31. 1 receptors by antisense oligodeoxynucleotides. Science (Washington DC). 259:1993;528-531.